Dermatitis, Seborrheic: Clinical Trials

3 trials for Dermatitis, Seborrheic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Unknown 1
Phase 21Completed 1

Follow Dermatitis, Seborrheic: new trials by email Literature Review of Dermatitis, Seborrheic trials Research Report on Dermatitis, Seborrheic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis
ZYG24002 0.5%, ZYG24002 0.75%, ZYG24002 1% - Seborrheic Dermatitis
Phase 1RecruitingSinomune Pharmaceutical Co., Ltd482026-04-242026-06-17
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult
Natural Treatment - Dermatitis, Seborrheic, Dry Skin; Eczema
Phase 1 / Phase 2CompletedAnn & Robert H Lurie Children's Hospital of Chicago772019-07-082025-02-24
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Botulinum toxin - Parkinson Disease, Parkinsonism
Phase 1UnknownRabin Medical Center402009-05-012008-10-07

Narrower conditions

Eczema (1)  ·  Parkinson Disease (1)  ·  Parkinsonian Disorders (1)

Broader conditions

Dermatitis (3)  ·  Sebaceous Gland Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Eczematous (3)  ·  Skin Diseases, Papulosquamous (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Synucleinopathies (1)

Interventions

Botulinum Toxins (1)

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Rabin Medical Center (1)  ·  Sinomune Pharmaceutical Co., Ltd (1)

Countries

China (1)  ·  United States (1)

Top investigators

Jun Gu, MD (1)  ·  Lucy Bilaver, PHD (1)